Mabel Toribio is an Instructor in Medicine at Harvard Medical School and a clinical investigator at Massachusetts General Hospital (MGH.) She received her MD from Johns Hopkins University School of Medicine. After finishing her internal medicine training at the University of California, San Francisco, she completed her Endocrinology training at MGH. Dr. Toribio's research focuses on HIV-associated cardiometabolic disease with a specific focus on transgender populations. She is dedicated to training students from underrepresented backgrounds in medicine.
At the completion of this educational session, learners will:
- To describe mechanisms of heightened atherosclerotic cardiovascular disease among people living with HIV.
- To discuss prevention and treatment strategies under investigation to mitigate atherosclerotic cardiovascular disease.
- To describe specific populations, i.e. transgender and cisgender women living with HIV, that may be at high risk for cardiovascular
This CME activity has approved for AMA PRA Category 1 Credit™
for September 23, 2020 as a live activity. This activity will also be available as an enduring activity from September 24, 2020, through September 22,2023.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™
. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun, DO (Course Director) has no relevant financial relationships to disclose.
- Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose.
- Dr. Toribio will support her presentation and clinical recommendations with the best available evidence from the medical literature and will submit her slides in advance for adequate peer review.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare
Click here to take the CME Evaluation and Post-Meeting Evaluation